Mainz-based German company BioNTech says it is ready to supply millions of coronavirus vaccines (Covid-19) by the end of this year.
BioNTech has teamed up with US pharmaceutical giant Pfizer to develop the vaccine. The vaccine is currently being tested on humans.
Both companies stated that if the vaccine succeeds and passes international standards, they would be able to produce hundreds of millions of vaccines by 2021.
The German Federal Institute for Vaccines and Biomedical Medicine approved a vaccine trial on April 22.
“The two companies estimate that it will be possible to supply millions of doses of the vaccine by the end of 2020, depending on the technical success of the development program and approval by the regulatory authorities,” stated a statement from Pfizer and BioNTech.
BioNTech said the first wave of volunteers had been given a trial vaccine dose of BNT162 in a Phase 1/2 clinical study in Germany.
“Twelve study participants have been vaccinated with the BNT162 vaccine trial in Germany since the start of the study on April 23, 2020,” the Mainz-based company said, as reported by CNN on Thursday (30/4).
So far there has been no information about the results of the trial so far. BioNTech said the trial was conducted on about 200 healthy volunteers aged 18 to 55 years.
Hundreds of volunteers were given a number of vaccine doses ranging from 1 to 100 micrograms in order to find the optimal dose for the benefit of further studies.
“The safety and immunogenicity of the vaccine will be investigated,” BioNTech said.
Meanwhile, Pfizer said it would begin testing its experimental vaccine in the US as soon as next week. The company insists the vaccine can be used for emergency needs starting next fall.
“The two companies (Pfizer and BioNTech) plan to conduct joint clinical trials for potential Covid-19 vaccines – which have commenced in Europe and the US in several research locations,” Pfizer said in its first quarter report released online on Tuesday.
Pfizer is not the only company with corona vaccine research that has the most potential at this time. Last week, scientists from the Jenner Institute at Oxford University, UK, began testing vaccines in humans.
The institute said if the trial results match, they are ready to supply the coronavirus vaccine in early September 2020.
Meanwhile, based on the latest report from the World Health Organization (WHO), so far there are 120 vaccines being tested throughout the world. Seven of them are currently being clinically tested.